Skip to main content
Home

Top menu InfoLep

  • About InfoLep
  • News & Events
  • e-learning.infoNTD.org
Home

Main navigation InfoLep

  • Leprosy [5]
    • Global and Regional Leprosy Situation
    • WHO Global Leprosy Strategy
    • ILEP Strategy
    • World Leprosy Day
    • Leprosy journals
  • Key topics [8]
    • Leprosy and COVID-19
    • Diagnostic tests
    • Prevention of leprosy [2]
      • Interventions to reduce transmission: post-exposure prophylaxis (PEP) [2]
        • LPEP Programme
        • PEP++ project
      • Interventions to reduce transmission: vaccines
    • Rehabilitation & prevention of disability [2]
      • Preventing leprosy-related disabilities in girls and boys
      • Self-care in leprosy
    • Leprosy Antibiotic Treatment
    • Stigma, discrimination & mental wellbeing [4]
      • World Leprosy Day 2022
      • Gender
      • Mental wellbeing
      • SARI Project
    • Bioarchaeology of leprosy
    • PEP4LEP 2.0 & PEP4LEP [1]
      • PEP4LEP project
  • Toolkits [6]
    • Guides on Stigma and Mental Wellbeing [5]
      • Guide 1. What are health-related stigma and mental wellbeing? [8]
        • 1. What is stigma?
        • 2. Why does stigma exist?
        • 3. What are the causes of stigma?
        • 4. Who stigmatises?
        • 5. How does it feel to experience stigma?
        • 6. What are the effects of stigma?
        • 7. Effects of stigma and discrimination on mental wellbeing
        • Annex Guide 1
      • Guide 2. How to reduce the impact of stigma [7]
        • 1. From undetected disease to diagnosis to support
        • 2. Individual-level interventions
        • 3. Group-level interventions
        • 4. Family-level interventions
        • 5. Referral
        • 6. Further reading
        • Annexes Guide 2
      • Guide 3. How to reduce sources of stigma [6]
        • 1. Background to the design of a stigma-reduction intervention
        • 2. Identifying the sources of stigma
        • 3. Targeting an intervention
        • 4. Inclusion of affected persons and champions in interventions
        • 5. Interventions by source type
        • Annexes Guide 3
      • Guide 4. How to assess health-related stigma and mental wellbeing [9]
        • 1. What is the purpose of the assessment?
        • 2. What approach would best fit your purpose and context?
        • 3. Quantitative assessment methods
        • 4. Qualitative assessment methods
        • 5. Assessments using mixed methods
        • 6. Developing qualitative methods from scratch
        • 7. How do you conduct a stigma assessment?
        • 8. How to interpret and report your findings
        • Annexes Guide 4
      • Glossary
    • NTD Morbidity and Disability Toolkit [15]
      • CHIEF
      • Clinical Profile
      • EMIC affected persons
      • EMIC-CS Community Stigma
      • Participation Scale
      • Patient Health Questionnaire (PHQ-9)
      • 5-Question Stigma Indicators
      • Salsa Scale
      • SARI Stigma Scale
      • SDS Social Distance Scale
      • SRQ Self-reporting Questionnaire
      • Warwick-Edinburgh Mental Wellbeing Scale (WEMWBS)
      • WGQ Washington Group Questions
      • WHODAS
      • WHOQOL-BREF
    • Perception Study Toolkit (PST)
    • Zero Leprosy Toolkit
    • CBM's Community Mental Health Good Practice Guides
    • GPZL & Infolep Factsheets
  • Online courses
  • Ocular DB

Top menu InfoLep

  • About InfoLep
  • News & Events
  • e-learning.infoNTD.org
Visit our e-learning platform
Search resources Search in Practical Materials, Publications, Organizations, Online Course and more
Publication

Assessment of knowledge and awareness about leprosy among medical college students in Tripoli

Amer H, Hariba Z. Journal of Science and Technology - Awlad Ali. 2023;
Download PDF
Publication

A implementação do teste anti-pgl1 no sistema único de saúde para rastreio de contactantes de hanseníase

Oliveira M. F, Costa M. de S. N. M, Fonseca A. M. M, et al. 2023: ANAIS DO IV COMA: CONGRESSO MÉDICO ACADÊMICO DA FACULDADE DE MEDICINA DE JUIZ DE FORA - UNIPAC-JF. 2023;
Download PDF
Publication

Lepromatous Leprosy Manifesting As Chronic Macrocheilia: Report of a Rare Case

Panigrahi R, Priyadarshini SR, Sahoo PK, et al. Springer Science and Business Media LLC. Cureus. 2023;
Download PDF
Publication

A Literature Review: Understanding TNF and IL-1 of the Main Cause of Thorombo-occlusive in Lucio’s Phenomenon

Simatupang E. G. H, Pratiwi U, Saint H. O, et al. International Journal of Health, Economics, and Social Sciences. 2023;
Download PDF
Publication

HSP60 mimetic peptides from Mycobacterium leprae as new antigens for immunodiagnosis of Leprosy.

Lima M, Corrêa M, Moraes E, et al. AMB Express. 2023; 13 (1) : 120.
Download PDF
Publication

Type 2 Leprosy Reaction Mimicking Leukocytoclastic Vasculitis in a Postpartum Patient.

Schaffenburg W, Royer M, Scorza M. The American Journal of dermatopathology. 2023;
Publication

Effective amelioration of the Lucio phenomenon with adjuvant tofacitinib therapy in a patient with dual infection of Mycobacterium leprae and Mycobacterium lepromatosis: a case report from India

Patel NH, Padhiyar JK, Patel KA, et al. Microbiology Society. Access Microbiology. 2023; 5 (10) : 1-9.
Download PDF
Publication

Leprosy.

The Independent practitioner. 1881; 2 (3) : 116.
Download PDF
Publication

Claw Hand Deformity in Leprosy

Zhao GZ, Venkatesh S, Zheng L, et al. Elsevier BV. The American Journal of Medicine. 2023;
Publication

Analysis Mycobacterium lepromatosis as the causative agent of diffuse lepromatous leprosy patient in Indonesia

Alinda MD, KARIM A, PUTRA BHK, et al. UNS Solo. Biodiversitas Journal of Biological Diversity. 2023;
Download PDF

Pagination

  • Previous page ‹‹
  • Page 51
  • Next page ››
Subscribe to Diagnosis

Quick links

  • Leprosy
  • Key topics
  • Toolbox
  • Publications

Support

  • Contact
  • Privacy statement
  • FAQ

Contact us

info@infolep.org

(+31) 20 595 0500

     

Stay up to date with the latest publications and news related to leprosy.

Subscribe to newsletter

Related websites:

© 2026 InfoNTD